75F40126F19004↗

Name: 75F40126F19004: Redefining Nonmedical Use of Buprenorphine and Methadone in the Addiction Severity Index-Multimedia Version (Asi-Mv) Clinical Assessment Tool
Creator: SpendQuery

REDEFINING NONMEDICAL USE OF BUPRENORPHINE AND METHADONE IN THE ADDICTION SEVERITY INDEX-MULTIMEDIA VERSION (ASI-MV) CLINICAL ASSESSMENT TOOL

Delivery Order · Food and Drug Administration · to Integrated Behavioral Health, Inc. (UEI L9YZF5SG6WN1) · data as of 2026-09-30

Obligated to date$46.3K1 action

Current value$46.3Kwith options exercised

Period2026-09-30 → 2027-09-29current end date

What it is

Product or service: Special Studies/Analysis- Scientific Data (PSC B529)
Industry: Research and Development in the Physical, Engineering, and Life Sciences (Except Nanotechnology and Biotechnology) (NAICS 541715)
Contracting office: Fda Office of Acq Grant Svcs (75F401)
Competition: Full and open competition · 1 offer received
Pricing: Firm fixed price
How it was bought: Multiple-award IDIQ · under 75F40121D00032
Where the work is: Montgomery, MD · district MD-08

Obligations by fiscal year

FY2026$46.3K

SpendQuery holds FY2023 on; earlier years are on USAspending.gov.

Subcontractors: where the money went next

No subawards reported for this award. Primes report subawards of $30,000 or more; many awards have none.

Every action

1 action since 2026-08-18. Each is a modification or amendment with the money it added or took back.

Date	Modification	Kind	Amount	What the agency wrote
2026-08-18	0		$46.3K	REDEFINING NONMEDICAL USE OF BUPRENORPHINE AND METHADONE IN THE ADDICTION SEVERITY INDEX-MULTIMEDIA VERSION (ASI-MV) CLINICAL ASSESSMENT TOOL

Source: USAspending.gov prime award transactions and FSRS subaward reports, as loaded by SpendQuery (data as of 2026-09-30). Amounts are obligations (money committed), not outlays. The official record on USAspending.gov ↗